Access Business Group Signs on for Distribution of PepZin GI(TM)

Fair Lawn, NJ (January 22, 2004) - Lonza announced that Access Business Group (ABG), a leader in product development and manufacturing, has signed on to use PepZin GI™, the newest supplement ingredient from Lonza, in one of its products. Access Business Group provides integrated services in development, formulation and manufacturing of dietary supplement products to a variety of companies. It is a respected resource for high-quality wellness, beauty and home care products. PepZin GI™, a patented dietary supplement ingredient with notable effects upon stomach health and function, will be the key ingredient in a new digestive product that ABG is developing.

This action follows extensive evaluation by the Research and Development staff at ABG. "We were impressed by the number of clinical trials demonstrating the beneficial effects of PepZin GI" stated Jim Roufs, MS, RD, who heads up New Concepts in the Nutrition R&D department at ABG. "And after reviewing the strength of the human studies as well as realizing just how many people are concerned about the health of their stomach, this clinically-tested and effective approach fits well within our brand philosophy."

“This is the third in a series of exclusive distribution arrangements to introduce PepZin GI™, a patented form of zinc-carnosine” said Dan Murray, an Associate Director in Lonza’s North American Nutrition Group. “We are pleased to expand our relationship with ABG, a responsible leader in the dietary supplement industry,” he added.
The product being developed by ABG opens up a new category in supplements by supporting the natural defense mechanism of the stomach through dietary supplementation. Lonza has an exclusive worldwide distribution agreement with Hamari Chemicals to market PepZin GI™ a patented form of zinc-carnosine.

Lonza is a life sciences driven company, headquartered in Switzerland, which generated sales of CHF 2.24 billion in 2003. It operates 18 production and R&D facilities in eight countries and employs 5660 people worldwide. Lonza is one of the leading custom manufacturers of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries. In addition, Lonza also offers organic intermediates for a wide range of applications and provides antimicrobial and associated products as well as polymer intermedi-ates and compounds. For more information please visit the company’s website at

For further information please contact:

Dan Murray - or - Christine Casper
Associate Director Nutrition Communications Manager
Tel +1 678 445 3535 Tel + 1 201 794 2448
Fax +1 678 445 3611 Fax + 1 201 794 2695
[email protected] [email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.